Hims & Hers Health shows 50% revenue growth, $1B in cash, and 2.4x 2026 sales with strong personalization and GLP-1 sales.

Hims announced that TRT therapy would be coming to its telehealth platform this year. But a grey market still thrives as ...

What the recent share performance signals for Hims & Hers Health (HIMS) Hims & Hers Health (HIMS) has drawn investor ...

Now looks like a great time to weigh in with options, as the equity's Schaeffer's Volatility Index (SVI) of 65% that ranks in ...

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, operates at the intersection of healthcare and proprietary technology by positioning its digital platform as the core engine ...

Hims & Hers stock has nosedived in the past few months. It has dived by over 56% from its highest point in July last year and ...

Hims & Hers Health, Inc. faces short-term pressure after missing Novo’s partner list, but lab testing boosts long-term growth ...

During 2025, Hims & Hers further deepened this foundation through targeted investments in data and AI. Leadership additions ...

Add Yahoo as a preferred source to see more of our stories on Google. The New York Stock Exchange with a Hims & Hers Health, Inc banner is pictured as a person runs past in the Manhattan borough of ...

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, built its growth strategy around a highly scalable, ...